A phase I/II study of percutaneous radiofrequency ablation for metastatic bone tumor (JIVROSG-0208)

Phase 1

• Conditions: Symptomatic metastatic bone tumor

• Registration Number: JPRN-C000000047
• Lead Sponsor: Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-08-07
• Study Completion: 2011-09-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

Not provided

Exclusion Criteria

1) Cardiac pacemaker. 2) Artery or nerve along the puncture route. 3) Pregnancy. 4) No symptom or VAS of less than 3.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adverse events

Secondary Outcome Measures

Name	Time	Method
Imrovement of symptom measured by Visual Analogue Scale at 1 week after the procedure.